4.6 Review

Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis

Related references

Note: Only part of the references are listed.
Review Infectious Diseases

100 years of Mycobacterium bovis bacille Calmette-Guerin

Christoph Lange et al.

Summary: The BCG vaccine, initially designed for cattle, has saved many lives since its first administration to a newborn in Paris in 1921. While providing strong protection against miliary and meningeal tuberculosis in children, it is less effective in preventing pulmonary tuberculosis in adults. It has also shown non-specific benefits against non-tuberculous infections and immunotherapeutic benefits in certain cancers.

LANCET INFECTIOUS DISEASES (2022)

Article Respiratory System

Tuberculosis prevention in children: a prospective community-based study in South Africa

Anna M. Mandalakas et al.

Summary: This study found that in high TB burden settings, providing children with isoniazid preventive therapy can significantly reduce their risk of developing tuberculosis, especially for children under 5 years of age or those living with HIV.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Public, Environmental & Occupational Health

Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling study

Partho Roy et al.

LANCET GLOBAL HEALTH (2019)

Article Public, Environmental & Occupational Health

The duration of protection of school-aged BCG vaccination in England: a population-based case-control study

Punam Mangtani et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)

Review Public, Environmental & Occupational Health

Transmission of Mycobacterium tuberculosis in Households and the Community: A Systematic Review and Meta-Analysis

Leonardo Martinez et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2017)

Review Medicine, General & Internal

Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data The PRISMA-IPD Statement

Lesley A. Stewart et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Article Multidisciplinary Sciences

Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries

Gwenan M. Knight et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Editorial Material Medicine, General & Internal

What is the efficiency of BCG?

Helene Vaillant-Roussel et al.

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2014)

Review Respiratory System

Contact investigation for tuberculosis: a systematic review and meta-analysis

Gregory J. Fox et al.

EUROPEAN RESPIRATORY JOURNAL (2013)

Article Multidisciplinary Sciences

Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered

Christopher Dye

JOURNAL OF THE ROYAL SOCIETY INTERFACE (2013)

Editorial Material Medicine, General & Internal

The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices

Alice Zwerling et al.

PLOS MEDICINE (2011)

Article Public, Environmental & Occupational Health

Tuberculin reaction, BCG scar, and lower female mortality

Adam Roth et al.

EPIDEMIOLOGY (2006)

Review Immunology

Bacillus Calmette-Guerin vaccination and infant mortality

Adam Roth et al.

EXPERT REVIEW OF VACCINES (2006)

Article Immunology

Adult-type pulmonary tuberculosis in children 10-14 years of age

BJ Marais et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)

Article Medicine, General & Internal

Long-term efficacy of BCG vaccine in American Indians and Alaska natives - A 60-year follow-up study

NE Aronson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)

Article Infectious Diseases

BCG: the challenge continues

PEM Fine

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2001)